Fonar Return on Tangible Equity 2012-2026 | FONR
Current and historical return on tangible equity values for Fonar (FONR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Fonar Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-03-31 | $0.01B | $0.16B | 4.52% |
| 2025-12-31 | $0.01B | $0.15B | 4.55% |
| 2025-09-30 | $0.01B | $0.15B | 4.58% |
| 2025-06-30 | $0.01B | $0.15B | 5.25% |
| 2025-03-31 | $0.01B | $0.15B | 5.28% |
| 2024-12-31 | $0.01B | $0.15B | 5.31% |
| 2024-09-30 | $0.01B | $0.15B | 6.66% |
| 2024-06-30 | $0.01B | $0.15B | 7.39% |
| 2024-03-31 | $0.01B | $0.15B | 7.48% |
| 2023-12-31 | $0.01B | $0.15B | 8.95% |
| 2023-09-30 | $0.01B | $0.14B | 7.69% |
| 2023-06-30 | $0.01B | $0.14B | 6.37% |
| 2023-03-31 | $0.01B | $0.14B | 7.14% |
| 2022-12-31 | $0.01B | $0.14B | 5.79% |
| 2022-09-30 | $0.01B | $0.14B | 7.31% |
| 2022-06-30 | $0.01B | $0.14B | 8.91% |
| 2022-03-31 | $0.01B | $0.13B | 8.33% |
| 2021-12-31 | $0.01B | $0.13B | 10.04% |
| 2021-09-30 | $0.01B | $0.13B | 9.45% |
| 2021-06-30 | $0.01B | $0.12B | 8.05% |
| 2021-03-31 | $0.01B | $0.12B | 8.20% |
| 2020-12-31 | $0.01B | $0.12B | 5.85% |
| 2020-09-30 | $0.01B | $0.12B | 5.93% |
| 2020-06-30 | $0.01B | $0.12B | 6.87% |
| 2020-03-31 | $0.01B | $0.11B | 9.63% |
| 2019-12-31 | $0.01B | $0.11B | 12.58% |
| 2019-09-30 | $0.01B | $0.11B | 13.05% |
| 2019-06-30 | $0.01B | $0.10B | 13.56% |
| 2019-03-31 | $0.02B | $0.10B | 19.14% |
| 2018-12-31 | $0.02B | $0.09B | 19.20% |
| 2018-09-30 | $0.02B | $0.09B | 21.47% |
| 2018-06-30 | $0.02B | $0.08B | 22.96% |
| 2018-03-31 | $0.02B | $0.08B | 20.65% |
| 2017-12-31 | $0.02B | $0.07B | 26.03% |
| 2017-09-30 | $0.02B | $0.07B | 28.15% |
| 2017-06-30 | $0.02B | $0.06B | 30.40% |
| 2017-03-31 | $0.02B | $0.06B | 33.33% |
| 2016-12-31 | $0.02B | $0.05B | 30.33% |
| 2016-09-30 | $0.02B | $0.05B | 30.15% |
| 2016-06-30 | $0.02B | $0.05B | 32.09% |
| 2016-03-31 | $0.01B | $0.04B | 31.64% |
| 2015-12-31 | $0.01B | $0.04B | 31.52% |
| 2015-09-30 | $0.01B | $0.04B | 30.38% |
| 2015-06-30 | $0.01B | $0.04B | 29.14% |
| 2015-03-31 | $0.01B | $0.04B | 27.59% |
| 2014-12-31 | $0.01B | $0.04B | 28.57% |
| 2014-09-30 | $0.01B | $0.03B | 30.77% |
| 2014-06-30 | $0.01B | $0.03B | 33.06% |
| 2014-03-31 | $0.01B | $0.03B | 36.04% |
| 2013-12-31 | $0.01B | $0.03B | 35.64% |
| 2013-09-30 | $0.01B | $0.02B | 38.55% |
| 2013-06-30 | $0.01B | $0.02B | 43.08% |
| 2013-03-31 | $0.00B | $0.01B | 33.33% |
| 2012-12-31 | $0.00B | $0.01B | 47.06% |
| 2012-09-30 | $0.00B | $0.01B | 57.14% |
| 2012-06-30 | $0.00B | $0.01B | 72.73% |
| 2012-03-31 | $0.00B | $0.00B | 70.59% |
| 2011-12-31 | $0.00B | $0.00B | 240.00% |
| 2011-09-30 | $0.00B | $0.00B | -150.00% |
| 2011-06-30 | $0.00B | $-0.01B | -40.00% |
| 2011-03-31 | $0.00B | $-0.01B | -25.00% |
| 2010-12-31 | $0.00B | $-0.01B | -10.53% |
| 2010-09-30 | $0.00B | $-0.01B | 9.76% |
| 2010-06-30 | $0.00B | $-0.01B | 28.57% |
| 2010-03-31 | $0.00B | $-0.01B | 30.00% |
| 2009-12-31 | $0.00B | $-0.01B | 21.62% |
| 2009-09-30 | $0.00B | $-0.01B | 0.00% |
| 2009-06-30 | $0.00B | $-0.01B | -23.53% |
| 2009-03-31 | $-0.01B | $-0.01B | 57.14% |
| 2008-12-31 | $-0.01B | $-0.01B | 120.00% |
| 2008-09-30 | $-0.01B | $-0.01B | 266.67% |
| 2008-06-30 | $-0.01B | $0.00B | 622.22% |
| 2008-03-31 | $-0.02B | $0.00B | -1600.00% |
| 2007-12-31 | $-0.02B | $0.01B | -378.95% |
| 2007-09-30 | $-0.02B | $0.01B | -205.41% |
| 2007-06-30 | $-0.03B | $0.01B | -175.44% |
| 2007-03-31 | $-0.03B | $0.02B | -128.21% |
| 2006-12-31 | $-0.03B | $0.03B | -109.09% |
| 2006-09-30 | $-0.03B | $0.03B | -89.26% |
| 2006-06-30 | $-0.03B | $0.04B | -82.27% |
| 2006-03-31 | $-0.02B | $0.04B | -49.08% |
| 2005-12-31 | $-0.01B | $0.04B | -29.38% |
| 2005-09-30 | $-0.01B | $0.05B | -15.38% |
| 2005-06-30 | $0.00B | $0.05B | 4.42% |
| 2005-03-31 | $0.00B | $0.04B | 0.00% |
| 2004-12-31 | $0.00B | $0.04B | -2.45% |
| 2004-09-30 | $-0.01B | $0.04B | -13.07% |
| 2004-06-30 | $-0.01B | $0.04B | -28.17% |
| 2004-03-31 | $-0.01B | $0.03B | -33.33% |
| 2003-12-31 | $-0.02B | $0.03B | -52.03% |
| 2003-09-30 | $-0.02B | $0.03B | -53.78% |
| 2003-06-30 | $-0.02B | $0.03B | -49.59% |
| 2003-03-31 | $-0.02B | $0.03B | -67.20% |
| 2002-12-31 | $-0.02B | $0.03B | -59.70% |
| 2002-09-30 | $-0.02B | $0.04B | -63.31% |
| 2002-06-30 | $-0.02B | $0.04B | -63.89% |
| 2002-03-31 | $-0.02B | $0.04B | -50.33% |
| 2001-12-31 | $-0.02B | $0.04B | -49.28% |
| 2001-09-30 | $-0.02B | $0.03B | -58.82% |
| 2001-06-30 | $-0.02B | $0.02B | -93.75% |
| 2001-03-31 | $-0.01B | $0.01B | -233.33% |
| 2000-12-31 | $-0.01B | 0 | 0.00% |
| 2000-09-30 | $-0.01B | $0.01B | -120.93% |
| 2000-03-31 | $-0.01B | $0.01B | -97.78% |
| 1998-12-31 | $-0.01B | $0.01B | -50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.115B | $0.104B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |